Nyumbani › Thrombocythemia ya Msingi › Illinois › Chicago
Majaribio ya kliniki ya Thrombocythemia ya Msingi katika Chicago, IL
Masomo 4 ya Thrombocythemia ya Msingi yanatafuta washiriki katika vituo vya Chicago na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
InaajiriHatua 2
- University of Chicago Comprehensive Cancer Center, Chicago
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
InaajiriHatua 3
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
- University of Chicago, Chicago
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
InaajiriHatua 1
- University of Chicago Medical Center, Chicago
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
InaajiriUtafiti wa uchunguzi
- MPN Research Foundation, Chicago
Majaribio ya Thrombocythemia ya Msingi katika miji mingine
- New York City, NYUtafiti 7
- Durham, NCUtafiti 6
- Miami, FLUtafiti 4
- Baltimore, MDUtafiti 4
- Nashville, TNUtafiti 4
- Salt Lake City, UTUtafiti 4
- Boston, MAUtafiti 4
- Mountain View, CAUtafiti 4
- Houston, TXUtafiti 3
- Columbus, OHUtafiti 3
- Cleveland, OHUtafiti 3
- St. Louis, MOUtafiti 3
Masomo mengine katika Chicago
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 61
- Saratani ya MatitiUtafiti 58
- Saratani (aina zote)Utafiti 51
- Saratani ya MetastasiUtafiti 45
- Saratani ya ProstateUtafiti 45
- UnenepuUtafiti 41
- Saratan ya MapafuUtafiti 41
- Kansari ya MayaiUtafiti 36
- KigonjwaUtafiti 34
- Kansari ya kolorektaliUtafiti 33
- Kushindwa kwa MoyoUtafiti 31
- Uzito Kupita KiasiUtafiti 28
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.